Effect of parenteral administration of GM1 on cytokines and anti-ganglioside antibody patterns. Preliminary report in normal human individuals. 1992

P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
2nd Department of Neurology, University of Padova, School of Medicine, Italy.

To assess the effects of monosialoganglioside GM1 on some immunological parameters, 12 healthy men were treated with 100 mg GM1 i.m. daily for 15 days. Before and after treatment, the following were studied: (1) serum levels of antibodies against GM1, asialo-GM1 (aGM1), GM2 and GD1b; (2) serum levels of interleukin (IL)-1 beta, IL-2, soluble IL-2 receptor (sIL-2R), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma); (3) IL-1 beta and TNF-alpha production by peripheral blood monocytes (PBMO). Anti-ganglioside antibody and cytokine serum levels were not affected by exogenous GM1 administration with the exception of a transient increase in anti-GM1 antibody titer observed in one subject. In addition, no inhibition of IL-1 beta and TNF-alpha production by PBMO was observed. These preliminary data do not support a potential immunogenic or immunomodulatory function for in vivo administered GM1.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
October 1990, The Journal of pharmacy and pharmacology,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
January 1990, Acta neurologica Scandinavica,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
October 2013, Neurology,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
February 1990, Neuroscience letters,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
October 1990, Biochemistry international,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
March 1994, Journal of neuroscience research,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
July 2002, Acta neurologica Scandinavica,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
August 1999, International journal of cancer,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
November 1997, Diabetologia,
P Gallo, and M G Piccinno, and B Tavolato, and M Innocenti, and L Callegaro, and G Kirschner, and R Bruno, and C Chizzolini, and M G Fiori
January 1957, International archives of allergy and applied immunology,
Copied contents to your clipboard!